Ismail Ali, Director of Policy and Advocacy at MAPS, passionately supports psychedelics as promising mental health treatments, particularly for those unresponsive to conventional therapies. In contrast, Kevin Sabet, former White House drug policy advisor, raises alarms about the unknown long-term effects of these substances. They dive into the ethical concerns of legalization, the need for rigorous regulation, and the ongoing debate surrounding the legitimacy of psychedelic research. Tune in for a thought-provoking clash on mental health and psychedelics!

Author Kevin A. Sabet and U.S. Armed Forces retiree Jonathan Lubecky engage in a fiery debate on marijuana legalization, exploring topics like medicinal benefits, commercialization, rescheduling, barriers to research, financial implications, and the use of marijuana as a medical alternative for veterans. The discussion delves into the complexities of federal regulations, industry influences, and the need for balanced drug policies in the U.S.